1. Home
  2. SND vs NSPR Comparison

SND vs NSPR Comparison

Compare SND & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Sand Inc.

SND

Smart Sand Inc.

HOLD

Current Price

$3.61

Market Cap

99.3M

Sector

Industrials

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.96

Market Cap

81.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SND
NSPR
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.3M
81.8M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
SND
NSPR
Price
$3.61
$1.96
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
557.8K
101.5K
Earning Date
11-12-2025
11-04-2025
Dividend Yield
2.46%
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$335,471,000.00
$7,779,000.00
Revenue This Year
N/A
$22.76
Revenue Next Year
N/A
$75.45
P/E Ratio
$40.65
N/A
Revenue Growth
18.98
14.04
52 Week Low
$1.76
$1.59
52 Week High
$4.51
$3.80

Technical Indicators

Market Signals
Indicator
SND
NSPR
Relative Strength Index (RSI) 56.50 49.41
Support Level $3.29 $1.86
Resistance Level $4.17 $2.00
Average True Range (ATR) 0.36 0.12
MACD 0.00 0.02
Stochastic Oscillator 45.71 56.41

Price Performance

Historical Comparison
SND
NSPR

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: